Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An adult-onset movement disorder characterized by bradykinesia, dysarthria and muscle rigidity.
Features include very common findings: Dysarthria, Muscle stiffness (rigidity), Slowness of movement (bradykinesia), and Dysdiadochokinesis and others; and common findings: Difficulty walking (gait disturbance) and Difficulty swallowing (dysphagia).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Dysarthria, Difficulty walking (gait disturbance), Difficulty swallowing (dysphagia) |
Biomarker and diagnostic research for striatal degeneration, autosomal dominant has been reported in the published literature.
Phenotype severity distribution: 5 very common features, 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for striatal degeneration, autosomal dominant.
15 publications have been identified in PubMed for striatal degeneration, autosomal dominant. Research spans Review / Meta-Analysis (40%), Basic Science / Preclinical (27%), and Case Report / Case Series (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 | 40% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 2:21 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Digestive system |
1 |
Difficulty swallowing (dysphagia) |
Laboratory research
4 |
27% |
Patient case studies | 2 | 13% |
New treatment approaches | 2 | 13% |
Testing and diagnosis research | 1 | 7% |
Marinina KS (2026). [PMID: 41739569](https://pubmed.ncbi.nlm.nih.gov/41739569/). *Journal of Huntington's disease*. [Basic Science / Preclinical]
Amro S (2026). [PMID: 42077578](https://pubmed.ncbi.nlm.nih.gov/42077578/). *World J Nucl Med*. [Case Report / Case Series]
Huang L (2026). [PMID: 41139934](https://pubmed.ncbi.nlm.nih.gov/41139934/). *Clinical genetics*. [Gene Therapy / Novel Therapeutics]
Williams ET (2026). [PMID: 42039388](https://pubmed.ncbi.nlm.nih.gov/42039388/). *bioRxiv*. [Basic Science / Preclinical]
Senousy MA (2026). [PMID: 42181874](https://pubmed.ncbi.nlm.nih.gov/42181874/). *Front Pharmacol*. [Review / Meta-Analysis]
Dontiboina HR (2026). [PMID: 42217109](https://pubmed.ncbi.nlm.nih.gov/42217109/). *Mol Neurobiol*. [Review / Meta-Analysis]
Barbagallo F (2025). [PMID: 39820109](https://pubmed.ncbi.nlm.nih.gov/39820109/). *Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology*. [Review / Meta-Analysis]
Scahill RI (2025). [PMID: 39825149](https://pubmed.ncbi.nlm.nih.gov/39825149/). *Nature medicine*. [Diagnostic / Biomarker]
Parsai LH (2025). [PMID: 40859407](https://pubmed.ncbi.nlm.nih.gov/40859407/). *Acta neuropathologica communications*. [Gene Therapy / Novel Therapeutics]
Roy SK (2025). [PMID: 39934995](https://pubmed.ncbi.nlm.nih.gov/39934995/). *Current gene therapy*. [Review / Meta-Analysis]